Charlotte Robinson

DocwireNews

Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, has announced that Amit Sharma, MD, FACP, FASN, FNKF, has joined its board as an independent, nonexecutive director.Dr. Sharma received his medical degree from Louisiana State University Medical Center in New Orleans and completed his nephrology and hypertension fellowship at the University of California, San Diego. He is certified by the American Board of Internal Medicine for internal medicine and nephrology and has an additional certification as a hypertension specialist by the American Society of Hypertension.Dr. Sharma has held various senior leadership roles at biotechnology companies and larger pharmaceutical companies. Currently, he is vice president of clinical development and therapeutic head for nephrology and hematology at Alexion, AstraZeneca Rare Disease. There, he guides and executes the strategic direction of products and programs within Alexion&rsquo;s nephrology franchise across all stages of development. Before joining Alexion, Dr. Sharma was vice president of medical affairs for the cardiovascular and renal division of Bayer Pharmaceuticals.&ldquo;We are pleased to welcome Dr. Sharma to our Board of Directors,&rdquo; said James F. Oliviero, president and chief executive officer of Checkpoint. &ldquo;He is a highly accomplished life sciences executive, with leadership experience in many facets of both patient care and the research, development, approval, and commercialization of pharmaceutical products.&rdquo;

Kaitlyn Kosko

Pembrolizumab Plus Trastuzumab/Pertuzumab Shows Promise in HER2-Positive Breast Cancer

HER2 Breast Cancer

MarkAlain Déry, DO, MPH, FACOI

Autism Rates Reach New High in U.S. Children: Here’s What It Really Means

Neurodivergent

Jordana Jampel

Annual US Measles Cases Top 1,000, Worst Year Since Elimination

Infectious Disease

Latest News

Checkpoint Therapeutics Appoints Amit Sharma, MD, to Board

Nephrology Times

Checkpoint Therapeutics has added Amit Sharma, MD, to its board.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe